Category Archives: AZBio News
Washington Rundown: What’s up at the nation’s capitol
Washington Rundown for April 3, 2013 as provided by BIO for the Council of State Bioscience Associations (CSBA)Continue reading
Azbil BioVigilant (ABV) Announces Partnership with University of Tennessee (UT) Pharmacy College
UT to Implement ABV’s Rapid Microbial Monitoring in New Aseptic Processing Area Continue reading
Opportunity Alert: Apply to present at AdvaMed 2013
Present your Company
at AdvaMed 2013
Now is your chance to be among the 60+ MedTech companies and Tech Transfer Offices who will present their latest products and technologies on Tuesday, September 24 and Wednesday, September 25 at AdvaMed 2013: The MedTech Conference in Washington, DC.
Company Presentations connect innovative MedTech companies with established industry business development executives, venture capitalists, angel and family fund investors, entrepreneurs, and other strategic partners.
Innovative MedTech companies are competitively selected to make 9-minute business development and investor presentations. If selected, the fee to present is $800 plus the applicable registration fee.
Additional benefits to presenting at and attending AdvaMed 2013:
- Investor Contact: Present to the industry’s top investors. Click here to view the list of 333 investors, business development, and finance executives who attended AdvaMed 2012.
- MedTech Partnering: Gain access to the MedTech Partnering system where you can schedule private meetings with attendees that you would like to see.
- Entrepreneurship Boot Camp: A full day of interactive sessions that provide smaller companies with insights and skills needed to address challenges in today’s competitive market.
- Marketing & PR: All presenting companies will be promoted on the AdvaMed 2013 website, in e-blasts, press releases, and in print materials including the AdvaMed 2013 Company Presentation book.
- Gain access to more than 40 educational panels, CEOs Unplugged sessions, and world-class thought leaders.
How To Apply
- Step 1: Submit your application through our website to present no later than May 24, 2013.
- Step 2: Applications will be reviewed and scored by a carefully selected committee.
- Step 3: All applicants will be notified if they have been accepted in late June.
Click here to submit your application.
SynCardia to expand with $19M in new financing
SynCardia Secures $19M Financing for Total Artificial Heart
$15M Financed by Athyrium Opportunities Fund, $4M by Existing ShareholdersContinue reading
A Look at the Power and Promise of Biologics
Video from the Alliance for Patient AccessContinue reading
Picking Winners and Losers
This week an opinion piece circulated via email from a nonprofit policy institute that claims to “stand on principle, not politics”. The writer used the example of Suntech, a solar company that has received business incentives here in Arizona as a prime example of why we should not use government funds to support or invest in specific companies or industries. Continue reading
Fiscal 2014 Budget Resolution with Medical Device Excise Tax Repeal Passes
The non-binding 2014 Budget Resolution in the Senate represents the first Senate vote on the repealof the medical device excise tax and is an important expression of the Senate’s support for addressing the issue.
UA Surgeon Works to Revolutionize Organ Transplantation
Dr. Zain Khalpey’s organ transplant research focuses on three key areas: bridge to regeneration, organ reconditioning and organogenesis, or the creation of new organs.Continue reading
2013 BIO Fly In – AZBio’s update from Capitol Hill
Last week, over 200 leaders from across the nation visited Washington D.C. to meet with their Congressional delegations and share ideas with our nation’s leaders on the importance of our bioindustry and on the issues that are key to moving innovation forward and providing access to these life sustaining and life saving innovations.Continue reading